Company profile: Meccellis Biotech
1.1 - Company Overview
Company description
- Provider of biomaterials and tissue and cell engineering, creating biological implants in dialogue with surgeons. Products include CELLIS, a preservative-free dermal matrix for varied surgeries; CELLIS Breast, a porcine dermis matrix for breast reconstruction; and CELLIS Dental, a non-pyrogenic acellular membrane for dental soft tissue repair.
Products and services
- CELLIS® Breast: Porcine dermis surgical matrix architected for breast reconstruction, utilizing a unique tissue acellularization process to deliver an acellular dermis implant
- CELLIS®: Engineered biological matrix for diverse surgical applications, preserving natural dermal structure without preservatives via tissue and cellular engineering with surgeons
- CELLIS® Dental: Non-pyrogenic acellular dermal matrix fabricated from porcine skin, used as a surgical membrane in dental surgeries for soft tissue repairs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Meccellis Biotech
ACell
HQ: United States
Website
- Description: Provider of extracellular matrix devices and acellular, resorbable MatriStem/UBM matrices for tissue repair and remodeling in surgical and wound care, including Cytal Wound Matrix, Cytal Burn Matrix, MicroMatrix UBM Particulate, and Gentrix Surgical Matrix.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ACell company profile →
Nerites
HQ: United States
Website
- Description: Provider of synthetic biomaterials designed to enhance natural tissue repair, reduce complications from traditional devices, and safely degrade when no longer needed.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nerites company profile →
Olivo Labs
HQ: United States
Website
- Description: Provider of proprietary biomaterials technology advancing the dermatological field, including its pioneering XPLTM "Second Skin" technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Olivo Labs company profile →
Artelon
HQ: United States
Website
- Description: Provider of bio-textile solutions for kinematic reinforcement of tendon and ligament reconstruction, developing synthetic materials for tissue reconstruction and restoring stability and motion. Products include FLEXBAND biomaterial and systems (Twist, Solo, Multi, FIX), FLEXBAND Plus, FLEXPATCH, Dynamic Matrix Technology used in over 60,000 implantations, and educational programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artelon company profile →
Kerecis
HQ: Iceland
Website
- Description: Provider of patented fish-skin and fatty acid-based products for cellular therapy, regenerative medicine, and wound/surgical care, including Kerecis Omega3 Wound, Omega3 SurgiClose, Omega3 SurgiBind, Omega3 GraftGuide, WOUND spray, and 1 Primary Wound Dressing spray; gently processed fish skin retains human skin-like structure with no disease-transfer risk from cold-water fish.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kerecis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Meccellis Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Meccellis Biotech
2.2 - Growth funds investing in similar companies to Meccellis Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Meccellis Biotech
4.2 - Public trading comparable groups for Meccellis Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →